Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-01 4:54 pm Sale | 2022-12-31 | 13G | Athira Pharma, Inc. ATHA | BlackRock Inc. BLK | 236,322 6.200% | -9,246 (-3.77%) | Filing History |
| 2023-01-30 1:38 pm Sale | 2022-12-31 | 13G | Athira Pharma, Inc. ATHA | FRANKLIN RESOURCES INC BEN | 0 0.000% | -208,005 (Position Closed) | Filing History |
| 2022-07-01 4:45 pm Purchase | 2022-06-30 | 13D | Athira Pharma, Inc. ATHA | Perceptive Advisors LLC | 481,115 12.800% | 138,523 (+40.43%) | Filing History |
| 2022-02-14 5:02 pm Sale | 2021-12-31 | 13G | Athira Pharma, Inc. ATHA | VIKING GLOBAL INVESTORS LP | 0 0.000% | -212,065 (Position Closed) | Filing History |
| 2022-02-14 4:14 pm Sale | 2021-12-31 | 13G | Athira Pharma, Inc. ATHA | Venrock Healthcare Capital Partners II, L.P. | 100,000 2.700% | -69,162 (-40.89%) | Filing History |
| 2022-02-14 08:09 am Sale | 2021-12-31 | 13G | Athira Pharma, Inc. ATHA | RTW Investments, LP | 190,656 5.100% | -77,922 (-29.01%) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Athira Pharma, Inc. ATHA | BlackRock Inc. BLK | 245,568 6.600% | 245,568 (New Position) | Filing History |
| 2022-02-03 11:55 am Purchase | 2021-12-31 | 13G | Athira Pharma, Inc. ATHA | FRANKLIN RESOURCES INC BEN | 208,005 5.600% | 208,005 (New Position) | Filing History |